Literature DB >> 9781382

Developing and testing integrated multicompartment models to describe a single-input multiple-output study using the SAAM II software system.

D M Foster1.   

Abstract

As measurement devices become more sophisticated, it is possible to design more complex input-output studies, i.e., studies where data are obtained from several sites in the system under study. To interpret the resulting data requires models which can integrate known information about the system under study while simultaneously describing the data. In this chapter, we will illustrate how to develop and test a model structure for a single-input multiple-output study using the SAAM II software system. This system has been designed to make the use of sound modeling principles easy. It will be assumed that a known amount of a radiolabeled substance was injected as a bolus into plasma, that this substance can bind to and be taken up by red cells, that its only route of elimination is through the urine, and that external measurements are possible over a target organ. The steps in developing a model structure will make use of SAAM II's forcing function capability to show how the system can be decoupled; this will permit us to postulate model structures for the various subsystems accessible to measurement. We will then show how to use this information to postulate a model describing all the data, and how to test this model structure. This will permit us to comment on those parts of the system not accessible for experimental measurement. We will end with a general discussion of how to test for goodness-of-fit and model order.

Mesh:

Substances:

Year:  1998        PMID: 9781382     DOI: 10.1007/978-1-4899-1959-5_4

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  15 in total

1.  Simultaneous vs. sequential analysis for population PK/PD data II: robustness of methods.

Authors:  Liping Zhang; Stuart L Beal; Lewis B Sheinerz
Journal:  J Pharmacokinet Pharmacodyn       Date:  2003-12       Impact factor: 2.745

2.  Simultaneous vs. sequential analysis for population PK/PD data I: best-case performance.

Authors:  Liping Zhang; Stuart L Beal; Lewis B Sheiner
Journal:  J Pharmacokinet Pharmacodyn       Date:  2003-12       Impact factor: 2.745

3.  In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18).

Authors:  Dean F Wong; Paul B Rosenberg; Yun Zhou; Anil Kumar; Vanessa Raymont; Hayden T Ravert; Robert F Dannals; Ayon Nandi; James R Brasić; Weiguo Ye; John Hilton; Constantine Lyketsos; Hank F Kung; Abhinay D Joshi; Daniel M Skovronsky; Michael J Pontecorvo
Journal:  J Nucl Med       Date:  2010-06       Impact factor: 10.057

4.  Development of a whole body physiologically based model to characterise the pharmacokinetics of benzodiazepines. 1: Estimation of rat tissue-plasma partition ratios.

Authors:  Ivelina Gueorguieva; Ivan A Nestorov; Susan Murby; Sophie Gisbert; Brent Collins; Kelly Dickens; Judith Duffy; Ziad Hussain; Malcolm Rowland
Journal:  J Pharmacokinet Pharmacodyn       Date:  2004-08       Impact factor: 2.745

5.  (18)F-MCL-524, an (18)F-Labeled Dopamine D2 and D3 Receptor Agonist Sensitive to Dopamine: A Preliminary PET Study.

Authors:  Sjoerd J Finnema; Vladimir Stepanov; Ryuji Nakao; Anna W Sromek; Tangzhi Zhang; John L Neumeyer; Susan R George; Philip Seeman; Michael G Stabin; Cathrine Jonsson; Lars Farde; Christer Halldin
Journal:  J Nucl Med       Date:  2014-05-01       Impact factor: 10.057

6.  Human brain imaging of α7 nAChR with [(18)F]ASEM: a new PET radiotracer for neuropsychiatry and determination of drug occupancy.

Authors:  Dean F Wong; Hiroto Kuwabara; Martin Pomper; Daniel P Holt; James R Brasic; Noble George; Boris Frolov; William Willis; Yongjun Gao; Heather Valentine; Ayon Nandi; Lorena Gapasin; Robert F Dannals; Andrew G Horti
Journal:  Mol Imaging Biol       Date:  2014-10       Impact factor: 3.488

7.  Whole body physiologically based modelling of β-blockers in the rat: events in tissues and plasma following an i.v. bolus dose.

Authors:  S Y A Cheung; T Rodgers; L Aarons; I Gueorguieva; G L Dickinson; S Murby; C Brown; B Collins; M Rowland
Journal:  Br J Pharmacol       Date:  2017-12-01       Impact factor: 8.739

8.  Analyzing multi-response data using forcing functions.

Authors:  Liping Zhang; Lewis B Sheiner
Journal:  J Pharmacokinet Pharmacodyn       Date:  2005-11-07       Impact factor: 2.745

9.  64Cu-MM-302 Positron Emission Tomography Quantifies Variability of Enhanced Permeability and Retention of Nanoparticles in Relation to Treatment Response in Patients with Metastatic Breast Cancer.

Authors:  Helen Lee; Anthony F Shields; Barry A Siegel; Kathy D Miller; Ian Krop; Cynthia X Ma; Patricia M LoRusso; Pamela N Munster; Karen Campbell; Daniel F Gaddy; Shannon C Leonard; Elena Geretti; Stephanie J Blocker; Dmitri B Kirpotin; Victor Moyo; Thomas J Wickham; Bart S Hendriks
Journal:  Clin Cancer Res       Date:  2017-03-15       Impact factor: 12.531

10.  Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: the role of associated risk factors.

Authors:  Lisa Bodei; Marta Cremonesi; Mahila Ferrari; Monica Pacifici; Chiara M Grana; Mirco Bartolomei; Silvia M Baio; Maddalena Sansovini; Giovanni Paganelli
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-04-22       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.